drugset / Trial / NCT01814189

Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment

NCT01814189

Phase 3 Completed 350 enrolled Shahid Beheshti University of Medical Sciences
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to show the efficacy of promethazine in management of patients with moderate to severe migraine

Timeline

Start
2013-01
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Promethazine Small molecule 50 mg Oral
Comparator Sumatriptan Unknown 50 mg Oral